3386.T JPX
Cosmo Bio Company,Limited
1W: +0.9%
1M: +0.6%
3M: +2.1%
YTD: -4.6%
1Y: +6.5%
3Y: +42.5%
5Y: +19.4%
¥1,288.00 ($8.16)
+34.00 (+2.71%)
Weekly Expected Move ±1.5%
¥1216
¥1235
¥1254
¥1273
¥1292
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$12.7B
+8.0% ▲
5Y CAGR: +5.6%
Total Liabilities
$2.7B
+24.8% ▲
5Y CAGR: +8.7%
Shareholders Equity
$9.4B
+4.5% ▲
5Y CAGR: +5.0%
Cash & Investments
$2.9B
+9.4% ▲
5Y CAGR: -2.0%
Total Debt
$20M
-9.1% ▼
5Y CAGR: +0.0%
Net Debt
-$2.7B
-15.0% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $3.3B | $3.0B | $2.8B | $2.4B | $2.7B |
| Short-Term Investments | $300M | $0 | $199M | $300M | $199M |
| Cash & ST Investments | $3.6B | $3.0B | $3.0B | $2.7B | $2.9B |
| Net Receivables | $2.7B | $2.8B | $2.9B | $3.0B | $3.1B |
| Inventory | $863M | $1.1B | $1.0B | $1.1B | $1.1B |
| Other Current Assets | $182M | $168M | $188M | $469M | $310M |
| Total Current Assets | $7.3B | $7.1B | $7.1B | $7.2B | $7.4B |
| Property, Plant & Equip. | $693M | $675M | $572M | $701M | $862M |
| Goodwill & Intangibles | $182M | $171M | $155M | $162M | $167M |
| Long-Term Investments | $1.4B | $2.1B | $2.6B | $3.6B | $3.8B |
| Other Non-Current Assets | $448M | $150M | $441M | $2M | $327M |
| Total Non-Current Assets | $2.8B | $3.2B | $3.8B | $4.5B | $5.2B |
| Total Assets | $10.1B | $10.3B | $10.9B | $11.7B | $12.7B |
| — Liabilities — | |||||
| Accounts Payable | $592M | $573M | $639M | $747M | $806M |
| Short-Term Debt | $20M | $20M | $20M | $20M | $20M |
| Deferred Revenue | $319M | $246M | $40M | $0 | $29M |
| Other Current Liabilities | $16M | $199M | $424M | $399M | $411M |
| Total Current Liabilities | $1.1B | $1.0B | $1.1B | $1.2B | $1.4B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $570M | $592M | $637M | $693M | $759M |
| Total Non-Current Liabilities | $662M | $658M | $724M | $1.0B | $1.3B |
| Total Liabilities | $1.8B | $1.7B | $1.8B | $2.2B | $2.7B |
| — Equity — | |||||
| Common Stock | $918M | $918M | $918M | $918M | $918M |
| Retained Earnings | $5.3B | $5.6B | $5.8B | $5.9B | $5.9B |
| Accumulated OCI | $575M | $530M | $653M | $1.2B | $1.7B |
| Total Stockholders Equity | $7.8B | $8.1B | $8.4B | $9.0B | $9.4B |
| Total Liabilities & Equity | $10.1B | $10.3B | $10.9B | $11.7B | $12.7B |
| — Key Metrics — | |||||
| Total Debt | $20M | $20M | $20M | $20M | $20M |
| Net Debt | -$3.2B | -$3.0B | -$2.8B | -$2.4B | -$2.7B |
| Total Investments | $1.7B | $2.1B | $2.8B | $3.9B | $4.0B |